Aging with HIV infection: A journey to the center of inflammAIDS, immunosenescence and neuroHIV

Immunology Letters

Volumn 162, Issue 1, 2014, Pages 329-333

  Nasi, Milena ^a   Pinti, Marcello ^a   De Biasi, Sara ^a   Gibellini, Lara ^a   Ferraro, Diana ^a   Mussini, Cristina ^a,b   Cossarizza, Andrea ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Aging; AIDS; HIV; Immune activation; Inflammation; Neurocognitive impairment

Indexed keywords

ALPHA SYNUCLEIN; AMYLOID BETA PROTEIN; APOLIPOPROTEIN E4; CRYOPYRIN; INFLAMMASOME; TAU PROTEIN; UBIQUITIN;

AGING; ARTICLE; BIOACCUMULATION; CARDIOVASCULAR DISEASE; CELL MIGRATION; CENTRAL NERVOUS SYSTEM; DISEASE SEVERITY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV ASSOCIATED DEMENTIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNOFLUORESCENCE; INNATE IMMUNITY; KIDNEY DISEASE; LIFE EXPECTANCY; LIVER DISEASE; MACROPHAGE FUNCTION; MALIGNANT NEOPLASTIC DISEASE; METABOLIC SYNDROME X; MONOCYTE; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; OSTEOPOROSIS; AGE; HIV INFECTIONS; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGY; IMMUNOMODULATION; INFLAMMATION; VIROLOGY;

AGE FACTORS; AGING; CENTRAL NERVOUS SYSTEM; HIV INFECTIONS; HIV-1; HUMANS; IMMUNITY, INNATE; INFLAMMATION; NEUROIMMUNOMODULATION;

EID: 84918559501     PISSN: 01652478     EISSN: 18790542     Source Type: Journal    
DOI: 10.1016/j.imlet.2014.06.012     Document Type: Article

References (73)

1. Guaraldi G., Cossarizza A., Franceschi C., Roverato A., Vaccher E., Tambussi G., et al. Life expectancy in the immune recovery era: the evolving scenario of the HIV epidemic in Northern Italy. J Acquir Immune Defic Syndr 2014, 65:175-181.
2. Desai S., Landay A. Early immune senescence in HIV disease. Curr HIV/AIDS Rep 2010, 7:4-10.
3. Effros R.B., Fletcher C.V., Gebo K., Halter J.B., Hazzard W.R., Horne F.M., et al. Aging and infectious diseases: workshop on HIV infection and aging: what is known and future research directions. Clin Infect Dis 2008, 47:542-553.
4. Nguyen N., Holodniy M. HIV infection in the elderly. Clin Interv Aging 2008, 3:453-472.
5. Effros R.B. Aging and HIV disease: synergistic immunological effects?. Handbook on immunosenescence 2009, 949-964. Springer, Netherlands. T. Fulop, C. Franceschi, K. Hirokawa, G. Pawelec (Eds.).
6. Antinori A., Arendt G., Becker J.T., Brew B.J., Byrd D.A., Cherner M., et al. Updated research nosology for HIV-associated neurocognitive disorders. Neurology 2007, 69:1789-1799.
7. Ghafouri M., Amini S., Khalili K., Sawaya B.E. HIV-1 associated dementia: symptoms and causes. Retrovirology 2006, 3:28.
8. Valcour V.G. HIV aging, and cognition: emerging issues. Top Antivir Med 2013, 21:119-123.
9. Ciccarelli N., Fabbiani M., Baldonero E., Fanti I., Cauda R., Di Giambenedetto S., et al. Effect of aging and human immunodeficiency virus infection on cognitive abilities. J Am Geriatr Soc 2012, 60:2048-2055.
10. Douek D.C. Immune activation, HIV persistence, and the cure. Top Antivir Med 2013, 21:128-132.
11. Deeks S.G., Tracy R., Douek D.C. Systemic effects of inflammation on health during chronic HIV infection. Immunity 2013, 39:633-645.
12. Mattapallil J.J., Douek D.C., Hill B., Nishimura Y., Martin M., Roederer M. Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection. Nature 2005, 434:1093-1097.
13. Brenchley J.M., Douek D.C. The mucosal barrier and immune activation in HIV pathogenesis. Curr Opin HIV AIDS 2008, 3:356-361.
14. Hooper L.V., Littman D.R., Macpherson A.J. Interactions between the microbiota and the immune system. Science 2012, 336:1268-1273.
15. Klatt N.R., Funderburg N.T., Brenchley J.M. Microbial translocation, immune activation, and HIV disease. Trends Microbiol 2013, 21:6-13.
16. Estes J.D., Harris L.D., Klatt N.R., Tabb B., Pittaluga S., Paiardini M., et al. Damaged intestinal epithelial integrity linked to microbial translocation in pathogenic simian immunodeficiency virus infections. PLoS Pathog 2010, 6:e1001052.
17. Klatt N.R., Estes J.D., Sun X., Ortiz A.M., Barber J.S., Harris L.D., et al. Loss of mucosal CD103+ DCs and IL-17+ and IL-22+ lymphocytes is associated with mucosal damage in SIV infection. Mucosal Immunol 2012, 5:646-657.
18. Brenchley J.M., Price D.A., Schacker T.W., Asher T.E., Silvestri G., Rao S., et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 2006, 12:1365-1371.
19. Marchetti G., Tincati C., Silvestri G. Microbial translocation in the pathogenesis of HIV infection and AIDS. Clin Microbiol Rev 2013, 26:2-18.
20. Sandler N.G., Douek D.C. Microbial translocation in HIV infection: causes, consequences and treatment opportunities. Nat Rev Microbiol 2012, 10:655-666.
21. Cossarizza A., Pinti M., Nasi M., Gibellini L., Manzini S., Roat E., et al. Increased plasma levels of extracellular mitochondrial DNA during HIV infection: a new role for mitochondrial damage-associated molecular patterns during inflammation. Mitochondrion 2011, 11:750-755.
22. Pinti M., Mussini C., Cossarizza A. Mitochondrial DNA: a proinflammatory 'enemy from within' during HIV infection?. Cell Death Dis 2012, 3:307.
23. Nasi M., Pinti M., Mussini C., Cossarizza A. Persistent inflammation in HIV infection: established concepts, new perspectives. Immunol Lett 2014, [Epub ahead of print]. 10.1016/j.imlet.2014.01.008.
24. Gannon P., Khan M.Z., Kolson D.L. Current understanding of HIV-associated neurocognitive disorders pathogenesis. Curr Opin Neurol 2011, 24:275-283.
25. Sinha B., Rubens M. Systemic immune activation in HIV and potential therapeutic options. Immunopharmacol Immunotoxicol 2014, 36:89-95.
26. Klatt N.R., Canary L.A., Sun X., Vinton C.L., Funderburg N.T., Morcock D.R., et al. Probiotic/prebiotic supplementation of antiretrovirals improves gastrointestinal immunity in SIV-infected macaques. J Clin Invest 2013, 123:903-907.
27. Goto Y., Panea C., Nakato G., Cebula A., Lee C., Diez M.G., et al. Segmented filamentous bacteria antigens presented by intestinal dendritic cells drive mucosal Th17 cell differentiation. Immunity 2014, 40:594-607.
28. Ranasinghe C. New advances in mucosal vaccination. Immunol Lett 2014, [Epub ahead of print]. 10.1016/j.imlet.2014.01.006.
29. de Souza R.D., Batista M.T., Luiz W.B., Cavalcante R.C., Amorim J.H., Bizerra R.S., et al. Bacillus subtilis spores as vaccine adjuvants: further insights into the mechanisms of action. PLOS ONE 2014, 9:e87454.
30. Franceschi C., Monti D., Barbieri D., Salvioli S., Grassilli E., Capri M., et al. Successful immunosenescence and the remodelling of immune responses with ageing. Nephrol Dial Transplant 1996, 11(Suppl. 9):18-25.
31. Pinti M., Cevenini E., Nasi M., De Biasi S., Salvioli S., Monti D., et al. Circulating mitochondrial DNA increases with age and is a familiar trait: implications for inflamm-aging. Eur J Immunol 2014, 44:1552-1562.
32. Franceschi C., Capri M., Monti D., Giunta S., Olivieri F., Sevini F., et al. Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans. Mech Ageing Dev 2007, 128:92-105.
33. Sebastian C., Espia M., Serra M., Celada A., Lloberas J. MacrophAging: a cellular and molecular review. Immunobiology 2005, 210:121-126.
34. Appay V., Sauce D. Immune activation and inflammation in HIV-1 infection: causes and consequences. J Pathol 2008, 214:231-241.
35. Pinti M., Nasi M., Lugli E., Gibellini L., Bertoncelli L., Roat E., et al. T cell homeostasis in centenarians: from the thymus to the periphery. Curr Pharm Des 2010, 16:597-603.
36. Nasi M., Troiano L., Lugli E., Pinti M., Ferraresi R., Monterastelli E., et al. Thymic output and functionality of the IL-7/IL-7 receptor system in centenarians: implications for the neolymphogenesis at the limit of human life. Aging Cell 2006, 5:167-175.
37. Sara De Biasi M.P., Nasi M., Gibellini L., Bertoncelli L., Manzini S., Mussini C., et al. HIV-1 infection and the aging of the immune system: facts, similarities and perspectives. J Exp Clin Med 2011, 3:143-150.
38. Ransohoff R.M., Brown M.A. Innate immunity in the central nervous system. J Clin Invest 2012, 122:1164-1171.
39. Streit W.J. Microglia as neuroprotective, immunocompetent cells of the CNS. Glia 2002, 40:133-139.
40. Streit W.J. Microglia and the response to brain injury. Ernst Schering Res Found Workshop 2002, 1:11-24.
41. Glass C.K., Saijo K., Winner B., Marchetto M.C., Gage F.H. Mechanisms underlying inflammation in neurodegeneration. Cell 2010, 140:918-934.
42. Walsh J.G., Muruve D.A., Power C. Inflammasomes in the CNS. Nat Rev Neurosci 2014, 15:84-97.
43. International AIDS Society Scientific Working Group on HIV Cure, Deeks S.G., Autran B., Berkhout B., Benkirane M., Cairns S., et al. Towards an HIV cure: a global scientific strategy. Nat Rev Immunol 2012, 12:607-614.
44. Orenstein J.M. Replication of HIV-1 in vivo and in vitro. Ultrastruct Pathol 2007, 31:151-167.
45. Carter C.A., Ehrlich L.S. Cell biology of HIV-1 infection of macrophages. Annu Rev Microbiol 2008, 62:425-443.
46. Bart J., Groen H.J., Hendrikse N.H., van der Graaf W.T., Vaalburg W., de Vries E.G. The blood-brain barrier and oncology: new insights into function and modulation. Cancer Treat Rev 2000, 26:449-462.
47. Ancuta P., Kamat A., Kunstman K.J., Kim E.Y., Autissier P., Wurcel A., et al. Microbial translocation is associated with increased monocyte activation and dementia in AIDS patients. PLoS ONE 2008, 3:e2516.
48. Eden A., Price R.W., Spudich S., Fuchs D., Hagberg L., Gisslen M. Immune activation of the central nervous system is still present after >4 years of effective highly active antiretroviral therapy. J Infect Dis 2007, 196:1779-1783.
49. Anthony I.C., Ramage S.N., Carnie F.W., Simmonds P., Bell J.E. Influence of HAART on HIV-related CNS disease and neuroinflammation. J Neuropathol Exp Neurol 2005, 64:529-536.
50. Ellis R., Langford D., Masliah E. HIV and antiretroviral therapy in the brain: neuronal injury and repair. Nat Rev Neurosci 2007, 8:33-44.
51. Jamilloux Y., Pierini R., Querenet M., Juruj C., Fauchais A.L., Jauberteau M.O., et al. Inflammasome activation restricts Legionella pneumophila replication in primary microglial cells through flagellin detection. Glia 2013, 61:539-549.
52. Youm Y.H., Grant R.W., McCabe L.R., Albarado D.C., Nguyen K.Y., Ravussin A., et al. Canonical Nlrp3 inflammasome links systemic low-grade inflammation to functional decline in aging. Cell Metab 2013, 18:519-532.
53. Valcour V., Shikuma C., Shiramizu B., Watters M., Poff P., Selnes O., et al. Higher frequency of dementia in older HIV-1 individuals: the Hawaii Aging with HIV-1 cohort. Neurology 2004, 63:822-827.
54. Sacktor N., Skolasky R., Selnes O.A., Watters M., Poff P., Shiramizu B., et al. Neuropsychological test profile differences between young and old human immunodeficiency virus-positive individuals. J Neurovirol 2007, 13:203-209.
55. Fabbiani M., Ciccarelli N., Tana M., Farina S., Baldonero E., Di Cristo V., et al. Cardiovascular risk factors and carotid intima-media thickness are associated with lower cognitive performance in HIV-infected patients. HIV Med 2013, 14:136-144.
56. Hardy D.J., Vance D.E. The neuropsychology of HIV/AIDS in older adults. Neuropsychol Rev 2009, 19:263-272.
57. Ernst T., Chang L. Effect of aging on brain metabolism in antiretroviral-naive HIV patients. AIDS 2004, 18(Suppl. 1):S61-S67.
58. Ettenhofer M.L., Hinkin C.H., Castellon S.A., Durvasula R., Ullman J., Lam M., et al. Aging, neurocognition, and medication adherence in HIV infection. Am J Geriatr Psychiatry 2009, 17:281-290.
59. Jahanshad N., Valcour V.G., Nir T.M., Kohannim O., Busovaca E., Nicolas K., et al. Disrupted brain networks in the aging HIV+ population. Brain Connect 2012, 2:335-344.
60. Deeks S.G. Immune dysfunction, inflammation, and accelerated aging in patients on antiretroviral therapy. Top HIV Med 2009, 17:118-123.
61. Xu J., Ikezu T. The comorbidity of HIV-associated neurocognitive disorders and Alzheimer's disease: a foreseeable medical challenge in post-HAART era. J Neuroimmune Pharmacol 2009, 4:200-212.
62. Valcour V., Sithinamsuwan P., Letendre S., Ances B. Pathogenesis of HIV in the central nervous system. Curr HIV/AIDS Rep 2011, 8:54-61.
63. Anthony I.C., Ramage S.N., Carnie F.W., Simmonds P., Bell J.E. Accelerated Tau deposition in the brains of individuals infected with human immunodeficiency virus-1 before and after the advent of highly active anti-retroviral therapy. Acta Neuropathol 2006, 111:529-538.
64. Khanlou N., Moore D.J., Chana G., Cherner M., Lazzaretto D., Dawes S., et al. Increased frequency of alpha-synuclein in the substantia nigra in human immunodeficiency virus infection. J Neurovirol 2009, 15:131-138.
65. Achim C.L., Adame A., Dumaop W., Everall I.P., Masliah E., Neurobehavioral Research Center Increased accumulation of intraneuronal amyloid beta in HIV-infected patients. J Neuroimmune Pharmacol 2009, 4:190-199.
66. Clifford D.B., Fagan A.M., Holtzman D.M., Morris J.C., Teshome M., Shah A.R., et al. CSF biomarkers of Alzheimer disease in HIV-associated neurologic disease. Neurology 2009, 73:1982-1987.
67. 11C-PiB: a case-control study. Neurology 2010, 75:111-115.
68. Gisslen M., Hagberg L., Brew B.J., Cinque P., Price R.W., Rosengren L. Elevated cerebrospinal fluid neurofilament light protein concentrations predict the development of AIDS dementia complex. J Infect Dis 2007, 195:1774-1778.
69. Vehmas A., Lieu J., Pardo C.A., McArthur J.C., Gartner S. Amyloid precursor protein expression in circulating monocytes and brain macrophages from patients with HIV-associated cognitive impairment. J Neuroimmunol 2004, 157:99-110.
70. Esiri M.M., Biddolph S.C., Morris C.S. Prevalence of Alzheimer plaques in AIDS. J Neurol Neurosurg Psychiatry 1998, 65:29-33.
71. Desplats P., Dumaop W., Smith D., Adame A., Everall I., Letendre S., et al. Molecular and pathologic insights from latent HIV-1 infection in the human brain. Neurology 2013, 80:1415-1423.
72. Brew B.J. Benefit or toxicity from neurologically targeted antiretroviral therapy. Clin Infect Dis 2010, 50:930-932.
73. Anthony I.C., Bell J.E. The neuropathology of HIV/AIDS. Int Rev Psychiatry 2008, 20:15-24.